SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019928
Filing Date
2018-08-07
Accepted
2018-08-07 16:11:45
Documents
67
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20180630.htm 10-Q 1840166
2 EX-31.1 dvax-ex311_10.htm EX-31.1 17715
3 EX-31.2 dvax-ex312_12.htm EX-31.2 17657
4 EX-32.1 dvax-ex321_8.htm EX-32.1 5952
5 EX-32.2 dvax-ex322_6.htm EX-32.2 6204
  Complete submission text file 0001564590-18-019928.txt   6767857

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20180630.xml EX-101.INS 1462824
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20180630.xsd EX-101.SCH 51040
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20180630_cal.xml EX-101.CAL 50875
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20180630_def.xml EX-101.DEF 184970
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20180630_lab.xml EX-101.LAB 396250
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20180630_pre.xml EX-101.PRE 309532
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 18998087
SIC: 2834 Pharmaceutical Preparations